IMO... CPRX has a presentation on 16 Apr 2010. They are discussing a paper by the lead investigator on Phase2 for CPP-109 (it did not meet primary endpoints, news release came out last year, midpoint). A government agency, NIDA, may be providing funding for additional clinical trials. Drug is for treatment of cocaine addition.
Market Data 
Markets 
AI
